Martijn Kleijwegt, Director at Eloxx Pharmaceuticals, Inc. (ELOX), bought 300,000 shares at $9.75 ($2.9M) on 2018-04-30, disclosed to the SEC on 2018-05-01.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Nothing distinguishes this filing.